Introduction
Interleukin-1 (IL-1) is a potent proinflammatory cytokine that plays a central role in the pathogenesis of inflammatory connective tissue diseases such as rheumatoid arthritis or periodontal disorders, as well as during sepsis and repair processes (Dinarello, 2002; Dayer, 2003; Braddock and Quinn, 2004) . Regarding pathologic conditions of the skin such as psoriasis, scleroderma and systemic lupus erythematosis, apparent dysregulation of IL-1 has been demonstrated. Interleukin-1 is produced constitutively by keratinocytes and released upon epidermal injury or irritation (Luger and Schwarz, 1990; West-Mays et al., 1995; Podolsky, 1997) . This, in turn, initiates the early phases of tissue repair and allows epidermal-mesenchymal interactions that control skin homeostasis.
One of the intracellular target molecules of IL-1 is the transcription factor c-fos, an immediate-early gene, also activated by a wide range of other stimuli, including growth factors, cytokines, cellular stress and UV irradiation (Robertson et al., 1995; Treisman, 1995; Ahn et al., 1998) . Fos proteins form heteromeric dimers with members of the Jun family to generate AP-1 complexes with transcriptional activity (Karin et al., 1997) . Such transcription factors are involved in the regulation of AP-1-dependent genes, are critical for cellular processes such as cell proliferation or invasion, and have been implicated in biological processes ranging from embryonic development to tissue repair, apoptosis and neoplasia (Angel et al., 2001; Shaulian and Karin, 2002) . Induction of Fos is a prerequisite for cytokineinduced metalloproteinase gene expression. High expression of these extracellular matrix-degrading enzymes exerts deleterious consequences to connective tissue integrity in inflammatory disorders such as rheumatoid arthritis, and is critical to convey the invasive phenotype of tumor cells (Vincenti et al., 1996; Westermarck and Kahari, 1999) .
The activity of the AP-1 proteins is selectively controlled by mitogen-activated protein kinases (MAPKs), a family of kinases that transmit signals from cell surface receptors to the nucleus, resulting in the activation of specific transcription factors including AP-1 members (Karin, 1996; Hazzalin and Mahadevan, 2002; Weston and Davis, 2002; Yang et al., 2003) . Activation of AP-1 through the MAP kinase cascade is essential to convey signaling initiated by IL-1 (Han et al., 2001; Kumar et al., 2001) . The MAPK family is divided into three subgroups, namely the extracellular signal-regulated kinases (ERKs), the stress-activated kinases also known as Jun N-terminal kinases (JNKs) and p38 kinase Strniskova et al., 2002) . mitogen-activated protein kinases activate transcription factors in the cell nucleus either by direct phosphorylation or indirectly via activation of other protein kinases. One example is mitogen-and stress-activated kinase 1 (MSK1), which is activated by MAPKs and is capable of specifically phosphorylating the cAMP response element binding protein (CREB) at serine 133, whereas MAPKs cannot (Deak et al., 1998) .
Previous studies have revealed that in embryonic stem cells mitogen-induced c-fos expression is mainly mediated by MAPK/ERK (Schuck et al., 2003) . Whether this activation mechanism is common in all cell types or whether proinflammatory cytokines employ a similar pathway remains unclear. We therefore analysed the signaling events leading to IL-1 stimulation of c-fos gene expression in HaCaT keratinocytes. We demonstrate that MAP kinases are crucial players in IL-1-induced c-fos gene activation, and identify the critical role of p38-driven MSK1 phosphorylation and subsequent CREB phosphorylation in this process. Also, we show that pharmacologic inhibition of MSK1 activity reduces the proliferation of both HaCaT keratinocytes and A431 human epidermoid carcinoma cells.
Results and discussion
Subconfluent HaCaT keratinocyte cultures were incubated with IL-1 (50 U/ml) and c-fos expression was determined by Northern blotting at various time points. As shown in Figure 1a , a rapid and transient activation of c-fos mRNA steady-state levels was detected, peaking at 40 min after addition of the cytokine, followed by a rapid decline to baseline expression after 60 min. Similar results have been obtained when c-fos mRNA steadystate levels were detected by quantitative real-time PCR (not shown). Also, a similar pattern of c-fos regulation by IL-1 was identified in the A431 human SCC line (not shown). Stimulation of HaCaT cells transiently transfected with a c-fos promoter/luciferase reporter construct resulted in a dose-dependent transactivation of the c-fos promoter, with a maximal induction of threefold obtained with 50 U/ml IL-1 (Figure 1b) .
Previously, it has been shown that c-fos induction is mediated by PKA and CREB in cells treated with lysophosphatidic acid (Schuck et al., 2003) . Thus, as a first attempt to delineate the intracellular events leading to c-fos gene induction by IL-1, we examined whether PKA activation and CREB phosphorylation occurred in response to IL-1. Accordingly, PKA activity was determined in a specific kinase assay performed on keratinocyte extracts following incubation with IL-1 over various time periods. As shown in Figure 2a and b, IL-1 rapidly activated PKA, with a peak in kinase activity detected between 15 and 30 min following cytokine addition to the culture medium. In parallel, Western blot analysis of CREB and P-CREB levels in HaCaT cells indicated rapid and transient phosphorylation of CREB in response to IL-1 (Figure 2c ), whereas at the mean time, no change in total CREB amounts was observed.
Phosphorylation of CREB on serine 133 (Ser133) increases its transcriptional activity by favoring its association with adaptor proteins, such as CREBbinding protein (CBP) (Andrisani, 1999) . It is thus a crucial event for the activation of the transcriptional machinery. In this context, CREB phosphorylation has been shown to be critical for c-fos gene transactivation in the context of UV irradiation, nitric oxide or NGF stimulation (Ahn et al., 1998) . To test whether CREB phosphorylation was also an important event in the context of IL-1-induced c-fos expression, we performed transient cell transfection experiments in which the response of the c-fos promoter to IL-1 was examined in the absence or presence of S133-CREB, a CREB mutant that cannot be phosphorylated by either PKA or MSK1 owing to a serine to alanine substitution of Ser133. Basal c-fos promoter activity was lower in cells expressing the CREB mutant. As shown in Figure 2d , Expression of S133-CREB abrogated c-fos promoter transactivation in response to IL-1, indicating that CREB phosphorylation is a critical event precluding the induction of the c-fos gene by IL-1.
As IL-1 has been shown to activate the COX pathway (Maier et al., 1990; Crofford et al., 1994) , subsequently leading to generation of PGE2 and activation of the (Hagiwara et al., 1993) , we next evaluated the possible implication of this pathway in keratinocytes. To this end, we used the non-selective COX inhibitor Indo, and NS-398, a selective inhibitor of cyclooxygenase-2. As shown in Figure 3a , neither Indo nor NS-398 at concentrations known to block PGE 2 synthesis were able to prevent CREB phosphoryation in response to IL-1. In addition, we also found that Indo did not oppose c-fos mRNA induction by IL-1 (Figure 3b ). Conversely, exogenous addition of PGE 2 to HaCaT culture medium did not provoke any significant elevation of c-fos mRNA steady-state levels (not shown). Together, these results rule out a significant role of the COX/prostaglandin pathway in mediating c-fos activation by IL-1 in keratinocytes, Incubations were continued for 40 min after which c-fos mRNA levels were detected by Northern blot analysis (top). Specificity of c-fos modulation and identical loading of RNA amounts were confirmed using a specific GAPDH probe (bottom). Results from a representative experiment are shown. 
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and indicate that CREB phosphorylation in response to IL-1 occurs via mechanisms that do not require prostaglandins.
Other cellular means to activate PKA and CREB include the MAPK pathways, which are known to play a role in c-fos gene activation by various stimuli, including UV irradiation, contact with the extracellular matrix or cytokines (Cavigelli et al., 1995; Karin, 1996; Price et al., 1996; Hazzalin et al., 1997) . We thus assessed the status of MAPK activation in response to IL-1 in HaCaT cells, using phospho-specific antibodies for ERK, p38, JNK, and the downstream kinase MSK1, a known CREB kinase that may be activated by either p38 or ERK depending on stimulus and cell type (Deak et al., 1998) . Results are presented in Figure 4 . Interleukin-1 treatment resulted in the rapid phosphorylation of JNK, ERK, p38, as well as MSK1 (Figures 4a-d , respectively). The peak of phosphorylation for all three MAPKs and for MSK1 was observed at the 30 min time point following IL-1 addition, with little differences between the different kinases.
As CREB phosphorylation is crucial for c-fos promoter transactivation by IL-1 (see above), we tried to determine which MAPK(s), if any, was involved in the process leading to CREB phosphorylation in response to IL-1. For this purpose, a pharmacologic approach targeting each of the MAPKs specifically was taken. Results are presented in Figure 5 . Firstly, we identified that the JNK inhibitor SP600125 had no effect on IL-1-induced CREB phosphorylation (Figure 5a ). Likewise, SP600125 did not oppose IL-1-induced c-fos expression, as measured by Northern analysis of c-fos mRNA steady-state levels (Figure 5b ). At the mean time, efficient blockade of JNK phosphorylation in response to IL-1 was verified (not shown). It appears, thus, that the JNK pathway is not involved in CREB activation and c-fos transactivation.
The MEK1 inhibitor PD98059 only slightly blocked CREB phosphorylation in response to IL-1 even at the highest concentration used (25 mM; Figure 6a ), although at the latter concentration, complete blockade of ERK phosphorylation in response to IL-1 was observed (not shown).
In sharp contrast with the data obtained with either the JNK inhibitor SP600125 or the MEK1 inhibitor PD98059, the p38 inhibitor SB203580 dose-dependently repressed CREB phosphorylation in response to IL-1 (Figure 6b ). Together, these data The situation is thus different from that existing in human airway epithelial cells, in which IL-1, as well as TNF-a, induces CREB phosphorylation via equally important ERK-and p38-dependent mechanisms that compensate each other (Song et al., 2003) .
We next examined the effect of MAPK inhibitors on both MSK1 activation and CREB phosphorylation in response to IL-1. As shown in Figure 7 , SB203580 efficiently prevented MSK phosphorylation induced by IL-1 (lane 3 vs lane 2), whereas PD98059 did not (lane 4 vs lane 2), suggesting that the p38 pathway, not ERK, is critical for MSK1 activation by IL-1 in HaCaT keratinocytes. It is interesting to note that MSK1 activation by either the ERK or p38 pathway is highly specific to extracellular stimuli, as it has been demonstrated that the p38 pathway is involved in MSK1 activation by UV or oxidative stress, whereas inhibition of the ERK cascade prevents MSK1 activation by phorbol esters or growth factors (Deak et al., 1998) . Parallel detection of the CREB phosphorylation status indicated that SB203580 and PD98059 exert an additive inhibitory activity on IL-1-induced CREB phosphorylation (lanes 3-5 vs lane 2), with a predominant role played by p38 in this phenomenon, consistent with the data presented in Figure 6 . Given the fact that CREB is a very good substrate for MSK1, it is likely that the p38 pathway, through the activation of MSK1, is responsible for most of CREB phosphorylation in response to IL-1. Interestingly, Ro31-8220, a serine-threonine kinase inhibitor that blocks MSK1 activity without affecting its phosphorylation, was very potent to fully abolish CREB phosphorylation in response to IL-1 (Figure 7 , lane 6 vs lane 2), consistent with a critical role for MSK1 in IL-1-induced CREB phosphorylation.
Pharmacological modulation of MAPK and MSK1 activity was next used to determine the implication of these kinases in c-fos induction by IL-1. As shown in Figure 8 , the effect of IL-1 on c-fos mRNA steady-state levels was strongly inhibited by the p38 and ERK inhibitors SB203580 and PD98059, which acted in an additive manner. In addition, c-fos induction by IL-1 was completely abolished by the MSK1 inhibitor Ro31-8220. Similar results were obtained with A431 cells (not shown). Next, to directly determine the effect of MSK1 and kinase-dead mutants on endogenous c-fos expression and its regulation by IL-1, COS-7 cells were electroporated with the various MSK1 expression vectors described in the Materials and methods section. In this cell type, high transfection efficiency allowed measurement of endogenous c-fos mRNA steady-state levels in each experimental condition, whereas we were unable to overexpress any of the MSK constructs in HaCaT cells (not shown). As shown in Figure 9 , wildtype MSK1 overexpression increased basal c-fos expression and potentiated the IL-1 response, whereas both kinase-dead mutants prevented c-fos induction by IL-1.
Together, the data presented in Figures 7-9 indicate a critical role played by MSK1 in the cascade leading to CREB phosphorylation and subsequent c-fos gene expression in response to IL-1. However, it appears that the ERK cascade, which plays little role in MSK1 activation and CREB phosphorylation in keratinocytes, Figure 6 IL-1-induced phosphorylation of CREB is MAPK p38 dependent. (a) Subconfluent HaCaT keratinocyte cultures were treated with IL-1 (50 U/ml) in the absence (À) or presence ( þ ) of different concentrations of (a) the ERK inhibitor PD98059 or (b) a specific MAPK p38 inhibitor SB203580. Incubations were continued for 30 min after which cells were lysed and samples processed for Western immunoblotting with specific antibodies for phospho-CREB and CREB. MSK1 is critical for c-fos induction by IL-1 M Schiller et al also significantly controls c-fos gene expression in response to IL-1. Indeed, it has been shown previously that ERK-mediated c-fos induction occurs via phosphorylation of ELK/TCF transcription factors that bind the serum response element of the c-fos promoter via the serum response factor (SRF) (Treisman, 1995) . The latter also recruits the CBP to further enhance c-fos expression (Ramirez et al., 1997) . Integrating our current findings with the known literature allows to hypothesize that p38 activation, through MSK1 phosphorylation and subsequent activation of CREB, and the ERK pathway, through its direct activation of the ELK/TCF transcription factors, converge downstream of the IL-1 receptors to activate c-fos gene expression in keratinocytes, whereas the COX/prostaglandin pathway does not appear to play any significant role in c-fos activation (Figure 10 ). Our results differ from those obtained in human embryonic kidney fibroblast 293 cells (Deak et al., 1998) and murine RAW264.7 macrophages (Caivano and Cohen, 2000) , where activators of the classical MAPK cascade and forskolin induce a similar degree of phosphorylation of CREB and ATF1. One possible explanation is that the MAPK activators used by these authors, EGF and the phorbol ester TPA, mainly activate MSK1 via the ERK cascade, at least in human embryonic kidney fibroblast 293 cells, as PD98059, and not SB203580, largely suppresses the activation of endogenous or transfected MSK1 (Deak et al., 1998) .
To determine the implication of MSK1 in the control of epithelial cell proliferation, HaCaT keratinocytes and A431 SCC cultures in logarithmic growth phase were incubated with the MSK1 inhibitor Ro31-8220. Cell proliferation was determined by MTT assay. Results presented in Figure 11 demonstrate that MSK1 inhibition results in potent inhibition of cell growth in both cell types, suggesting a positive role for MSK1 in cell cycle control.
In summary, our present results demonstrate that both the ERK and p38 MAPK pathways contribute to the upregulation of c-fos gene expression in HaCaT keratinocytes in response to IL-1 stimulation, whereas the COX/prostaglandin pathway does not. We identify CREB phosphorylation by a p38/MAPK-MSK1 pathway as an event necessary for c-fos induction. At the mean time, we provide evidence that the ERK pathway, which is unable to activate MSK1 in HaCaT keratinocytes, contributes significantly to c-fos gene transactivation. On the other hand, although PKA is readily activated by IL-1 in HaCaT cells, it does not seem to significantly contribute to c-fos induction. These results provide new support to the concept that c-fos gene regulation requires multiple interdependent transcriptional control mechanisms. Finally, we identify MSK1 as a positive regulator of epithelial cell proliferation.
Materials and methods
Cell culture and biochemical reagents Human epidermal HaCaT keratinocytes, A431 human epidermoid carcinoma cell line and COS7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM glutamine and antibiotics (100 U/ml penicillin, 50 mg/ml streptomycin-G and 0.25 mg/ml Fungizonet) in a humidified atmosphere of 5% CO 2 . Recombinant human IL-1b was purchased from R&D Systems Inc. (Minneapolis, MN, USA) . It is referred to as IL-1 throughout the text. The ERK, JNK and p38 inhibitors (PD98059, SP600125 and SB203580, respectively) were purchased from Calbiochem. The PKA/MSK inhibitor H-89, the cyclooxygenase (COX) inhibitors indomethacin (Indo) and NS-398, prostaglandin E 2 (PGE 2 ) and the MSK1 inhibitor Ro31-8220 were from Sigma Chemical Co., Saint-Louis, MO, USA. 
Plasmid constructs
The mouse c-fos promoter/luciferase construct (Wang et al., 1995) was a kind gift from Dr Erwin F Wagner (IMP, Vienna, Austria). pCMV-CREB133 (Gonzalez and Montminy, 1989) encoding the S133-CREB mutant, was a gift from Dr DD Ginty (Johns Hopkins University Medical School, Baltimore, MD, USA) The expression vectors pCMV5-FLAG MSK1 WT and MSK1 dead kinase (MSK1 C-terminal kinase dead (CDK) and MSK1 N-terminal kinase dead (NKD)) were provided by Dr D Alessi (Protein Phosphorylation Unit, University of Dundee, Scotland) (Deak et al., 1998) .
Transient cell transfections
For reporter assays, HaCaT cells were seeded in 35 mm diameter dishes and transfected at approximately 60-70% confluency with the polycationic compound Fugenet (Roche Diagnostics, Indianapolis, IN,USA) in fresh medium containing 1% FCS. Interleukin-1 was added as needed, 6 h after transfection. Following a 24-h incubation, cells were rinsed twice with phosphate-buffered saline, harvested by scraping and lysed in 100 ml of reporter lysis buffer (Promega Corp., Madison, WI, USA). Aliquots corresponding to identical protein amounts were used for each reporter assay. Luciferase activity was determined with a commercial assay kit according to the manufacturer's protocol (Promega). For transfection experiments involving gene expression assays by quantitative real-time PCR, COS7 cells (5 Â 10 6 ), grown in DMEM containing 10% FCS, were washed once with PBS and resuspended in 300 ml of ice-cold transfection buffer (140 mM NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 , 6 mM glucose; 0.1 mM b-mercaptoethanol, 20 mM HEPES, pH 7.0) containing 1.25% DMSO. Cells were electroporated with 20 mg of MSK1 expression plasmids as required, or with the corresponding empty vector, using a Nucleofectort (Amaxa, Cologne, Germany). Transfection efficiency ranged from 70 to 80% as estimated with a GFP expression vector transfected in parallel (pmaxGFP, Amaxa).
Northern blotting
Total RNA was obtained using an RNeasy kit (Qiagen GmbH, Hilden, Germany) and analysed by Northern hybridization (20 mg/lane) with 32 P-labeled cDNA probes for c-fos and GAPDH, as described previously (Mauviel et al., 1993) . Hybridization signal was quantified with a phosphorimager (Storm 840, Amersham-Pharmacia Biotech, Uppsala, Sweden).
Western blotting
Subconfluent HaCaT cells were placed in fresh medium containing 1% FCS for 24 h before stimulation with various cAMP-elevating agents. The cells were washed with cold PBS and lysed in SDS lysis buffer (100 mM Tris-HCl (pH 6.8), 1% SDS, 0.1 M dithiothreitol, 0.1 mM orthovanadate) followed by boiling for 5 min. Proteins (50 mg/lane) were separated on 10 or 12% SDS-polyacrylamide gels and transferred to nitrocellulose Hybond ECL þ (Amersham-Pharmacia). After blocking with 5% non-fat dry milk in 20 mM Tris (pH 7.6), 137 mM NaCl and 0.1% Tween 20 for 1 h at room temperature, membranes were incubated with primary antibodies in blocking solution overnight at 41C: anti-CREB (1:2000 dilution) and anti-phospho-CREB (P-CREB) (Ser133, 1:1000 dilution), both from New England Biolabs (Beverly, MA, USA) anti-phospho-p38 MAP kinase (Thr180/Tyr182, 1:1000 dilution), anti-phospho-p44/42 (Erk1 and Erk2, Thr202/ Tyr204) E10 monoclonal antibody (1:2000 dilution), antiphospho-SAPK/JNK (Thr183/Tyr185, 1:1000 dilution) and anti-phospho-MSK1 (Thr581, 1:1000 dilution), all from Cell Signaling Technology (Beverly, MA, USA), anti-JNK1 (1:1000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-actin (1:5000 dilution, Sigma Co., Saint-Louis, MO, MSK1 is critical for c-fos induction by IL-1 M Schiller et al USA). After three washes in 20 mM Tris (pH 7.6), 137 mM NaCl and 0.1% Tween 20, membranes were incubated with species-specific (anti-rabbit or anti-mouse) IgG-horseradish peroxidase-conjugated antibodies (1:5000 dilution) (Santa Cruz Biotechnology) in blocking solution for 1 h at room temperature. Subsequently, membranes were washed three times with wash buffer (see above), and detection of immunoreactive proteins was performed with the ECL þ chemiluminescent reagent using a Storm 840 phosphorimager (Amersham Pharmacia Biotech), according to the manufacturer's instructions.
PKA-Assay PKA activity was measured using a commercial assay kit (Promega, Madison, WI, USA), utilizing a fluorescent PKAspecific peptide substrate. In brief, subconfluent HaCaT seeded in six well plates were serum-starved overnight before stimulation as indicated. The cells were harvested and samples processed according to the manufacturer's protocol. Results are expressed as a percentage of maximal activity above background as measured with excess cAMP.
Quantitative real-time PCR Total RNA was isolated using a commercial purification kit (Promega, Madison, WI, USA). Following DNAse I treatment of RNA samples, cDNAs were synthesized using oligo-dT primers and RevertAidt M-MuLV reverse transcriptase (Fermentas Life Sciences, Hanover, MD, USA), according to the manufacturer's instructions. Quantitative real-time PCR was performed in a total volume of 10 ml with SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA), and a 200 nM concentration of each primer. Primers were designed with the computer program Primer Express (Applied Biosystems), using parameters recommended by the manufacturer. Primer sequences for c-fos (GenBank accession number: NM_005252) are 5 0 -GGATAGCCTCTCTTACTAC CACTCACC-3 0 (forward primer) and 5 0 -AATGAAGTTGG CACTGGAGACG-3 0 (reverse primer), resulting in the amplification of a 112 bp fragment. Reactions were carried out in duplicate in an ABI-prism 7000 sequence detector supplied with SDS 2.1 software (Applied Biosystems), using the following conditions: an initial activation step (2 min at 501C), a single denaturation step (15 min at 951C), followed by 40 cycles of 15 s at 951C and 60 s at 601C, and a final cycle of 15 s at 951C, 15 s at 601C and 15 s at 951C. Levels of gene expression in each sample were quantified using the 2 ÀDDCT method (after validation assays for each gene primer set) as described (Livak and Schmittgen, 2001 ), using b-actin gene expression as an endogenous control (b-actin primers: 5 0 -GT GGGGCGCCCCAGGCACCA-3 0 and 5 0 -CTCCTTAATGT CACGCACGATTTC-3 0 ). For each condition, the ground condition was set as 1 and expression data are presented as bar graphs of average expression values 7s.d.
Proliferation assay A431 and HaCaT cells (1 Â 10 5 ) were seeded in 24-well culture plates and subsequently treated with the MSK1 inhibitor Ro31-8220 for 12, 24 and 48 h. After treatment, the cells were incubated with MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 0.5 mg/ml; Sigma Chemical Co.) at 371C for 4 h, then solubilized in a buffer containing 0.1 mg/ ml SDS and 0.5 mg/ml formamide at room temperature overnight. The spectrophotometric absorbance (570 nm) of the samples was measured with a microplate reader.
Abbreviations CREB, cAMP response element binding protein; FCS, fetal calf serum; IL-1, interleukin-1; MAPK, mitogen-activated protein kinase; MSK, mitogen-and stress-activated kinase; PKA, protein kinase A.
